Journal of Hand Surgery
Volume 33, Issue 7 , Pages 1211-1214, September 2008

Current Management of Onychomycosis

  • Kara S. Nunley, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Kara S. Nunley, MD, Division of Dermatology, Washington University School of Medicine, Campus Box 8123, 660 South Euclid Ave., St. Louis, MO 63110-1010
    • ,
  • Lynn Cornelius, MD

Division of Dermatology, Washington University School of Medicine, St. Louis, MO

Received 18 April 2008; accepted 26 May 2008.

Onychomycosis is the most common single cause of nail dystrophy and has a marked impact on quality of life. The availability of newer topical and systemic antifungal agents has improved our ability to effectively treat this condition. This article will review the most commonly used therapies and discuss the relative advantages and disadvantages of different treatment strategies.

Key words: Antifungal, fungal nail infections, nail dystrophy, onychomycosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.

PII: S0363-5023(08)00436-X

doi:10.1016/j.jhsa.2008.05.028

Journal of Hand Surgery
Volume 33, Issue 7 , Pages 1211-1214, September 2008

Article Tools